Cargando...
Tumor responsiveness to statins requires overexpression of the ARF6 pathway
The mevalonate pathway results in the prenylation of small GTPases, which are pivotal for oncogenesis and cancer malignancies. However, inhibitors of this pathway, such as statins, have not necessarily produced favorable results in clinical trials. We recently identified properties of statin respond...
Guardado en:
| Publicado en: | Mol Cell Oncol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Taylor & Francis
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4972113/ https://ncbi.nlm.nih.gov/pubmed/27652329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2016.1185564 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|